GE vs PFE: Which Is the Better Buy?

Side-by-side comparison of GE Aerospace and Pfizer Inc. — fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-05.

GE Aerospace · Industrials

$284.60

-24.0% upside to fair value

Grade B High Quality

PFE

Pfizer Inc. · Healthcare

$26.33

+28.6% upside to fair value

Grade B

QuantHub Verdict

PFE has more upside to fair value (+28.6%). PFE trades at a lower forward P/E (19.3x). These are model outputs — not personalized investment advice. See all research →

Valuation & Fundamentals

Metric	GE	PFE
Current Price	$284.60	$26.33
Fair Value Estimate	$216.30	$33.85
Upside to Fair Value	-24.0%	+28.6%
Market Cap	$297.4B	$149.8B
Forward P/E	34.1x	19.3x
EV / EBITDA	27.9x	12.9x
Price / Sales	6.2x	2.4x
Price / FCF	39.8x	16.5x
Revenue Growth YoY	+24.7%	-1.2%
Gross Margin	34.8%	70.3%
Operating Margin	18.5%	24.7%
Return on Equity	46.4%	8.7%
Dividend Yield	0%	0%
FCF Yield	2.51%	6.06%
Analyst Consensus	Strong Buy	Hold

Investment Thesis

GE — GE Aerospace

GE Aerospace is a leading player in the aerospace and defense industry, specializing in jet engines and propulsion technologies with a strong presence in commercial engines and defense propulsion segments. The company benefits from a high-quality management team led by CEO H. Lawrence Culp, Jr., who has extensive experience in operational transformation and aerospace leadership. Despite a premium…

PFE — Pfizer Inc.

Pfizer Inc. is a leading global pharmaceutical company specializing in drug manufacturing with a strong presence in vaccines, oncology, and primary care. The company benefits from a seasoned leadership team under CEO Albert Bourla, who has driven a strategic transformation focusing on science-driven innovation and portfolio optimization. Despite a high gross margin of 70.3% and solid operating ma…

Accumulation Zones

Metric	GE	PFE
Zone Low	$162.23	$25.39
Zone High	$183.86	$28.77
In Buy Zone?	No	Yes

← GE Research PFE Research → All Research